New cell therapy trial offers hope for Tough-to-Treat stomach cancer
NCT ID NCT07212933
Summary
This study is testing whether a new cell therapy called RAK, made from umbilical cord blood, can help control advanced stomach cancer that has stopped responding to standard treatments. Researchers will compare the therapy against a control group in 90 patients to see if it extends life, delays cancer growth, and is safe. The goal is to see if this biological therapy can become a new option for patients who have run out of other choices.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First＆Fifth Medical Center of Chinese PLA General Hospital
RECRUITINGBeijing, Beijing Municipality, 100853, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.